Skip to content

Coffee Intake Biomarker Validation and Association With Respiratory Diseases

Coffee Intake Biomarker Validation and Association With Respiratory Diseases

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07391696
Enrollment
100
Registered
2026-02-06
Start date
2020-10-01
Completion date
2026-12-31
Last updated
2026-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coffee

Brief summary

This proposed project aims to identify and validate biomarkers of coffee exposure in the Singapore population, and assess the association between coffee consumption (via biomarker measurements) and risk of respiratory diseases in a prospective multi-ethnic cohort in Singapore. Specific Aim 1: To identify and quantify urinary/serum metabolite changes that are associated with coffee consumption in a dose-response intervention study.

Interventions

DIETARY_SUPPLEMENTCoffee A

Week 1: coffee A ≤10 g coffee powder for low dose Week 2: non-coffee consumption (post-consumption kinetics) Week 3: coffee A ≤20 g coffee powder for medium dose Week 4: non-coffee consumption (post-consumption kinetics) Week 5: coffee A ≤40 g coffee powder for high dose Week 6: non-coffee consumption (post-consumption kinetics)

DIETARY_SUPPLEMENTCoffee B

Week 7: coffee B ≤40 g coffee powder for high dose Week 8: non-coffee consumption (post-consumption kinetics)

DIETARY_SUPPLEMENTTea

Week 9: washout Week 10: tea (control) Week 11: non-coffee consumption (post-consumption kinetics)

Sponsors

National University of Singapore
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to 64 Years
Healthy volunteers
Yes

Inclusion criteria

* Regular coffee drinkers aged 21-64 years old, Chinese ethnicity

Exclusion criteria

* Healthy individuals who are regular coffee and/or tea drinkers, aged 21-64 years old of Chinese ethnicity with no severe medical conditions and are physically-abled, can participate in the research. However, you cannot participate in or will be released from this study if the following conditions or situations apply to you: * Ineligible screening survey which will consist of basic demographic information and questions pertaining to inclusion/

Design outcomes

Primary

MeasureTime frameDescription
Urinary and serum metabolite changes associated with coffee consumption12weekUrine and serum samples will undergo a combination of targeted and untargeted metabolomic profiling at the Singapore Phenome Centre located at NTU. Briefly, thawed urine, serum, coffee and tea samples will be analysed directly on the UHPLC-TQ-MS. Secondly, to explore potentially novel biomarkers and/or metabolites related to the consumption of the two types of coffee relevant to Singapore (black coffee and coffee with additives), untargeted metabolomics will be conducted on the urine and serum samples.

Countries

Singapore

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 7, 2026